Table 2.
Association between baseline cardiometabolic multimorbidity and changes in the number of ADL and IADL disabilities over 7 years
| CM status | (ADL + IADL) | ADL | IADL | |||
|---|---|---|---|---|---|---|
| β (95%CI) | P | β (95%CI) | P | β (95%CI) | P | |
| Time, years | 0.13 (0.12 to 0.15) | < 0.001 | 0.07 (0.06 to 0.08) | < 0.001 | 0.07 (0.06 to 0.08) | < 0.001 |
| Intercept | ||||||
| non-CM | Reference | Reference | Reference | |||
| CM | 0.57 (0.41 to 0.73) | < 0.001 | 0.27 (0.18 to 0.36) | < 0.001 | 0.30 (0.20 to 0.39) | < 0.001 |
| Slope | ||||||
| Time × non-CM | Reference | Reference | Reference | |||
| Time × CM | 0.13 (0.05 to 0.21) | < 0.001 | 0.07 (0.03 to 0.12) | 0.001 | 0.05 (0.01 to 0.10) | 0.018 |
Notes Adjusted for age, sex, education, marital, residential location, smoking, alcohol consumption, body mass index, other non-communicable diseases and depressive symptoms. CM, cardiometabolic multimorbidity; CI, confidence interval; ADL, activities of daily living; IADL, instrumental activities of daily living